SciELO - Scientific Electronic Library Online

 
vol.32 issue2Orthodontist precautions in caring for periodontally affected patients author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista Facultad de Odontología Universidad de Antioquia

Print version ISSN 0121-246X

Rev Fac Odontol Univ Antioq vol.32 no.2 Medellín July/Dec. 2020

https://doi.org/10.17533/udea.rfo.v32n2a10 

Case Report

Angiolymphoid hyperplasia: report of an unusual case in the oral cavity**

Hiperplasia angiolinfoide: reporte de un caso inusual en cavidad oral

Eilien Tovío-Martínez1  * 

Samuel Urbano Del Valle2 

Laura Anaya-Guzmán3 

Diana Rivera-Peñates4 

1 DDS. Specialist in Stomatology and Oral Surgery, Researcher at the GITOUC Group, School of Dentistry, Universidad de Cartagena, Colombia. ORCID: https://orcid.org/0000-0003-3702-2791

2 DDS. Specialist in Stomatology and Oral Surgery, Researcher at the GITOUC Group, School of Dentistry, Universidad de Cartagena, Colombia. ORCID: https://orcid.org/0000-0002-5773-8642

3 Young researcher, GITOUC school of young researchers, School of Dentistry, Universidad de Cartagena, Colombia. ORCID: https://orcid.org/0000-0002-1729-8523

4 Young researcher, GITOUC school of young researchers, School of Dentistry, Universidad de Cartagena, Colombia. ORCID: https://orcid.org/0000-0002-9885-1780


Abstract

Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rare inflammatory disease of unknown origin, which may be asymptomatic or produce symptoms like pruritus, pain, or spontaneous bleeding, and which has no sex predilection. The treatment options are cryosurgery, pulsed dye laser, topical tacrolimus, surgery, curettage, and oral retinoids. Below is a report of a clinical case of angiolymphoid hyperplasia with eosinophilia in the oral cavity, as well as the treatment performed. This was a female patient who attended a stomatology and oral surgery clinic due to a localized lesion at the level of the vestibule between dental organs 11 and 12. Clinically, there was a nodular lesion of about 1 cm in diameter, located at the level of attached gingiva; it was asymptomatic on palpation and of unknown etiology. Angiolymphoid hyperplasia is an unusual pathology in the oral cavity; its etiology is unknown, and a definitive diagnosis should be made through histopathological examination and clinical signs.

Keywords: angiolymphoid hyperplasia with eosinophilia; gingiva; oral mucosa; oral surgery; diagnosis; therapeutics

Resumen

La hiperplasia angiolinfoide con eosinofilia (HACE) es una enfermedad rara de origen desconocido, de carácter inflamatorio, que puede ser asintomática o presentarse con prurito, dolor o sangrado espontáneo, sin predilección por género. Las opciones de tratamiento son la criocirugía, el láser de colorante pulsado, el tacrolimus tópico, la cirugía, el curetaje y los retinoides orales. Se reporta un caso clínico de hyperplasia angiolinfoide con eosinofilia en cavidad oral, así como el tratamiento realizado. Paciente de sexo femenino, que acudió a consulta de estomatología y cirugía oral por presentar lesión localizada a nivel de vestíbulo entre órganos dentarios 11 y 12. Clínicamente se observó lesión nodular localizada en encía adherida de aproximadamente 1 cm de diámetro, asintomático a la palpación y de etiología desconocida. La hyperplasia angiolinfoide es una patología inusual en cavidad oral, de etiología desconocida, en la que el diagnóstico definitivo debe hacerse a través del examen histopatológico y los signos clínicos.

Palabras clave: hyperplasia angiolinfoide; con eosinofilia; encía; mucosa bucal; cirugía bucal; diagnóstico; terapéutica

INTRODUCTION

Angiolymphoid hyperplasia with eosinophilia (ALHE), also known as epithelioid hemangioma or histiocytoid hemangioma, is a rare inflammatory vascular alteration of unknown origin, with a benign evolution and with periods of recurrence after surgical treatment.1 It is unclear whether ALHE occurs more often in men or women, and reports in the medical literature are contradictory.2

Its pathogenesis is unknown, but it is considered to be a reactive disorder induced by various stimuli, including vascular malformations, trauma, and pregnancy.3 The presence of high serum estrogen levels (also the case in the use of oral contraceptives) is one of the hypotheses; however, currently the most accepted theory is that of a reactional vascular hyperplasia caused by different stimuli.4 A case of dermal ALHE was found to harbor a mutation in the TEK gene, which encodes the Tie-2 endothelial cell tyrosine kinase receptor, showing that certain molecular alterations may contribute to the pathogenesis of this condition.5

Clinically, there can be erythematous or brownish papules of about 0.5-1 cm in diameter, and subcutaneous plaques or lesions that mainly affect the head and neck, especially in the periauricular region. It can also appear in maxillary bones, salivary glands, muscle tissues, and skin.6 The oral mucosa is a rare site, with few reports in the literature, but when it occurs, the most affected sites are the lips, the jugal mucosa, and the tongue.4 ALHE can be asymptomatic or produce pruritus, pain, or spontaneous bleeding; however, little is known about how often symptoms occur.2

Histologically, it is characterized by well-formed but often immature vessels, which are delineated by an endothelium of epithelioid form cells associated with a prominent inflammatory infiltrate including lymphocytes, mastocytes, eosinophils, and sometimes lymphoid follicles.7 Two main histological components are found: one inflammatory and one vascular. The degree of infiltration by eosinophils varies, but the lack of these puts the diagnosis of ALHE into question.8

The misdiagnosis of this condition is related to the high recurrence of the disease after initial treatment. Dermatoscopy and histopathological examination are necessary to diagnose this entity, providing a better healing rate.9 Panoramic, periapical, and occlusal x-rays usually show no alteration.10

The main differential diagnosis is Kimura disease, which is most common in Asian patients and occurs as deep nodules or subcutaneous lesions that typically affect the major salivary glands and regional lymph nodes; this is associated with the elevation of peripheral blood eosinophil count and IgE levels. Other diseases that should be considered in differential diagnosis include Kaposi sarcoma, angiosarcoma, and hemangioendothelioma.3 ALHE is a pathology of low prevalence and it rarely occurs in the oral cavity; when it happens, differential diagnosis includes benign neoplasms of salivary glands (mainly pleomorphic adenoma) and of other tissues such as leiomyoma, neurofibromas, and lipomas.

Various treatments have been reported, but due to its low incidence, there is no standardized treatment.12 Treatment options include cryosurgery, pulse dye laser, topical tacrolimus, surgery, curettage, and oral retinoids.8 The variety of attempted treatment options probably reflects a knowledge gap in the pathogenesis of ALHE.2

As this is a rare condition, the objective of this article is to report the unusual location of angiolymphoid hyperplasia in the oral cavity, which has become a challenge for dental practitioners in terms of diagnosis; in addition, the clinical, radiographic, and histological findings will be described.

CASE REPORT

A 32-year-old female patient consulted the stomatology and oral surgery clinic due to a nodular lesion in gingiva, of approximately 4 months of evolution, asymptomatic, without any kind of treatment. The patient had routine blood tests, reporting hemoglobin 12.9 gr/L, leukocytes 8,300 mm3, eosinophils 700/L, lymphocytes 4,600/mm3, neutrophils 5,000/mm3, and platelet count 280,000 mm3, showing a mild eosinophilia, with no pharmacological history, hypersensitivity reactions, or immune or allergic diseases.

The intraoral examination showed a nodular lesion located at the level of free gingiva of the right upper central incisor, of the same color of adjacent mucosa with a violet central region, which was maintained despite the increase in size. The lesion was approximately 1 cm in diameter, asymptomatic to palpation, of fluctuating consistency, with liquid content, 4 months of evolution, and unknown etiology. Clinically, the lesion did not coincide with infectious processes, and the images showed no bone compromise. The patient had had bimaxillary orthodontic appliance for about 1 year, which was still active (Figure 1).

Figure 1 Clinical view of free gingiva lesion on top right quadrant 

Following asepsis and antisepsis, the surgical approach was performed under local anesthesia by Parstch operation or semilunar incision and partial-thickness flap lift (Figure 2). After the excision, the lesion was sent for histopathological analysis (Figure 3). Three profuse rinses were performed with saline solution, conducting hemostasis, and taking suture points with 4.0 polyglycolic acid. The histological study showed a proliferation of blood capillaries with a thick vascular wall, endothelial cells, partial obliteration of vascular light and an infiltrate with significant infiltration of eosinophils. The definitive anatomopathological report was “angiolymphoid hyperplasia with eosinophilia”.

Figure 2 Lesion exposure 

Figure 3 Macroscopic view of the resected specimen 

A follow-up 8 days after surgery showed stitches in place. These were removed, showing good clinical healing and recovery of soft tissues. No relapse has occurred after 10 months of follow up.

DISCUSSION

Angiolymphoid hyperplasia with eosinophilia is an unusual benign pathology clinically characterized by the presence of unique or multiple angiomatous lesions frequently located on the scalp and face, and less frequently in the oral mucosa of young adults.8 In the present case there is an unusual location in the oral cavity, specifically in the free gingiva. In 2013, Singh et al reported no contribution of periapical, panoramic, and occlusal x-rays to diagnose angiolymphoid hyperplasia with eosinophilia because these show no alterations,10 just as in the present case, where no imaging alterations are reported.

In 2016, Da Rocha et al described divisional biopsy under local anesthesia as a diagnostic method, obtaining small fragments of soft tissue, which were fixed in 10% formalin for histopathological analysis. In most cases there was a benign vascular lesion characterized by the proliferation of blood capillaries with thick vascular wall as well as a significant inflammatory component composed of lymphocytes, plasmacytes, and numerous eosinophils.4 All this is consistent with the present case, where the same alterations were found in the histological analysis.

In 2014, Lorente et al reported the presence of eosinophilia in blood tests, with no changes in other lab parameters, which could suggest a diagnosis of angiolymphoid hyperplasia with eosinophilia.5 This is exactly the same in the present case, where mild eosinophilia and other normal values were reported, which helped established the diagnosis once the complementary tests were examined.

In 2016, Adler et al reported 593 cases, documenting specific monotherapy or combination therapy. Surgical excision was the most reported therapeutic intervention for ALHE (44.2%). Treatment failure (defined as incomplete disease resolution or recurrence after treatment) was lower in cases treated with excision (40.8%).2 Such surgical procedure and result were seen in the present case, which was monitored after 10 months with no signs of relapse.

In 2011, Kukreja et al reported that ALHE lesions are superficial and contain blood vessels of different luminal sizes, some of which may not be channeled, coated by a distinctive endothelium of epithelioid appearance. Eosinophilic abscesses are not seen and peripheral eosinophilia is not always present.13 On the other hand, in 2019 Wortsman et al commented that vascular changes are characteristic of ALHE, the vascular component shows proliferation of endothelial cells, including epithelioid or histiocytoid, some vessels are immature or poorly channeled, the light of some vessels may be occluded by the hypertrophy and protrusion of these cells, showing thickening of the wall of blood vessels with concentric rings of fibrosis and edema separating the cubic endothelial cells, some of them sometimes contain vacuolate cytoplasm, it has nuclei with irregular folds, cytoplasm in moderate quantity, strongly eosinophilic and vacuolate, sometimes diffuse or marked infiltrated lymphocytes and plasma cells with or without lymphoid follicles, the location of lymphoid commitment to the periphery is common, except in dermal lesions.14 This is consistent with the present case in which the histological study showed a proliferation of blood capillaries with thick vascular wall, endothelial cells, partial obliteration of vascular light, and an infiltrate with significant infiltration of eosinophils (Figures 4A and 4B).

Figure 4 Microphotographs showing the presence of eosinophilia and vascular proliferation. A. 10X. B. 40X 

CONCLUSION

Angiolymphoid hyperplasia is a benign lesion with an unusual location in the oral cavity that presents unspecific symptoms and etiology. However, in this case there were no symptoms, so the diagnosis was done through clinical and histopathological findings only. The treatment of choice was surgical, showing no evidence of recurrence to date. On the other hand, the details found in the x-ray study are of no relevance. Therefore, reporting lesions caused by this entity is considered important in order to contribute to a better understanding not only of its clinical or radiographic behavior, but also its biological and histological manifestations.

REFERENCES

1. Acosta Arias Y, del Risco Turiño C. Hiperplasia angiolinfoide con eosinofilia. Revista Cubana de Angiología. 2018; 19(2): 162-70. [ Links ]

2. Adler B, Krausz A, Minuti A, Silverberg J, Lev-Tov H. Epidemiology and treatment of angiolymphoid hyperplasia with eosinophilia (ALHE): a systematic review. J Am Acad Dermatol. 2016; 74(3): 505-12. DOI: https://doi.org/10.1016/j.jaad.2015.10.011Links ]

3. Guinovart R, Bassas-Vila J, Morell L, Ferrándiz C. Angiolymphoid hyperplasia with eosinophilia: a clinicopathologic study of 9 cases. Actas Dermosifiliogr. 2014; 105 (2): e1e6. DOI: https://doi.org/10.1016/j.adengl.2013.03.012Links ]

4. Da Rocha J, Goes A, Peixe P, Pereira de Oliveira D, Guedes L. Hiperplasia angiolinfoide com eosinofilia: um caso raro em cavidade oral: relato de caso. J Vasc Bras. 2016; 15(4):317-21. DOI: https://dx.doi.org/10.1590%2F1677-5449.004516Links ]

5. Guo R, Gavino AC. Angiolymphoid hyperplasia with eosinophilia. Arch Pathol Lab Med. 2015; 139(5): 683-86. DOI: https://dx.doi.org/10.5858/arpa.2013-0334-RSLinks ]

6. Lorente Luna M, Alfageme Roldán F, Suárez Messa D, Jiménez Blázquez E. Patrón en ovillo de lana como hallazgo ecográfico característico de hiperplasia angiolinfoide con eosinofilia. Actas Dermosifiliogr. 2014; 105(7): 718-20. DOI: https://dx.doi.org/10.1016/j.ad.2013.10.013Links ]

7. Rolón M, Gómez C, Díaz B, Merlo A, Duque A, Cardona M. Hiperplasia angiolinfoide en espécimen de expansión tisular: reporte de caso. Rev Colomb Cancerol. 2013; 17(1): 25-8. [ Links ]

8. Ruiz J, Solange I, Anaya J, Valdez P. Hiperplasia angiolinfoide con eosinofilia. Dermatol Argent. 2017; 23 (2): 92-9. [ Links ]

9. Santosa C, Wardhana M, Saputra H. Angiolymphoid hyperplasia with eosinophilia with clinical pictures of keratoacanthoma: a rare case report. Clin Case Rep. 2019; 7(1): 89-192. DOI: https://dx.doi.org/10.1002%2Fccr3.1949Links ]

10. Singh P, Singh A. A rare case of angiolymphoid hyperplasia with eosinophilia in the submental region. J Oral Maxillofac Pathol. 2013; 17(2): 311-4. [ Links ]

11. Salinas O, Corredoira Y, Rojas G. Hiperplasia angiolinfoidea con eosinofilia: presentación de un caso en cavidad oral y revisión de la literatura. Rev Méd Chile. 2007; 135(5): 636-39. DOI: http://dx.doi.org/10.4067/S0034-98872007000500012Links ]

12. Forero J, Uribe P, Tovar A. Hiperplasia angiolinfoide con eosinofilia: respuesta a la criocirugía y al tratamiento con corticoesteroides sistémicos e intralesionales. Dermatol Rev Mex. 2018; 62(1): 56-61. [ Links ]

13. Kukreja N, Koslowski M, Insall R. Angiolymphoid hyperplasia with eosinophilia presenting as an axillary artery aneurysm. BMJ Case Rep. 2011; 1-4. DOI: https://dx.doi.org/10.1136%2Fbcr.02.2011.3836Links ]

14. Wortsman X, Yagnam M, Carreño L. Morfología ecográfica en placa pseudonodular hipervascular en hiperplasia angiolinfoide. Actas Dermosifiliogr. 2019; 110(4): 303-7. DOI: https://doi.org/10.1016/10.1016/j.ad.2017.09.029Links ]

** Tovío-Martínez E, Urbano-Del Valle S, Anaya-Guzmán L, Rivera-Peñates D. Angiolymphoid hyperplasia: report of an unusual case in the oral cavity. Rev Fac Odontol Univ Antioq. 2020; 32(2): 109-116. DOI: http://dx.doi.org/10.17533/udea.rfo.v32n2a10

ETHICAL DISCLOSURE The authors state that no experiments were conducted on humans or animals for this study.

DATA CONFIDENTIALITY The authors state that they have followed their workplace’s protocols on the publication of patient data.

RIGHT TO PRIVACY AND INFORMED CONSENT The authors have obtained a written informed consent from the patients or subjects mentioned in the article. The corresponding author is in possession of this document.

Received: April 13, 2019; Accepted: September 03, 2019

*CORRESPONDING AUTHOR Eilien Tovío Martínez, Facultad de Odontología Universidad de Cartagena, (+57) (304) 335-8857, etoviom@unicartagena.edu.co, Barrio Zaragocilla, Campus de la Salud, Cartagena. D.T y C, Colombia.

CONFLICTS OF INTEREST

The authors state that they have no conflict of interest.

Creative Commons License This is an open-access article distributed under the terms of the Creative Commons Attribution License